Wells Fargo’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,373
| Closed | -$1.03K | – | 7842 |
|
|
2022
Q4 | $1.03K | Buy |
2,373
+2,011
| +556% | +$653 | ﹤0.01% | 6179 |
|
|
2022
Q3 | $0 | Buy |
362
+2
| +0.6% | +$1 | ﹤0.01% | 7776 |
|
|
2022
Q2 | $0 | Buy |
360
+23
| +7% | +$10 | ﹤0.01% | 7873 |
|
|
2022
Q1 | $0 | Buy |
337
+2
| +0.6% | +$2 | ﹤0.01% | 8187 |
|
|
2021
Q4 | $0 | Sell |
335
-497
| -60% | -$882 | ﹤0.01% | 8116 |
|
|
2021
Q3 | $2K | Buy |
832
+73
| +10% | +$159 | ﹤0.01% | 6624 |
|
|
2021
Q2 | $2K | Buy |
759
+253
| +50% | +$629 | ﹤0.01% | 6588 |
|
|
2021
Q1 | $1K | Sell |
506
-35,609
| -99% | -$101K | ﹤0.01% | 6805 |
|
|
2020
Q4 | $100K | Buy |
36,115
+35,984
| +27,469% | +$105K | ﹤0.01% | 5361 |
|
|
2020
Q3 | $1K | Hold |
131
| – | – | ﹤0.01% | 6257 |
|
|
2020
Q2 | $0 | Hold |
131
| – | – | ﹤0.01% | 7044 |
|
|
2020
Q1 | $0 | Sell |
131
-187
| -59% | -$675 | ﹤0.01% | 7047 |
|
|
2019
Q4 | $2K | Hold |
318
| – | – | ﹤0.01% | 6205 |
|
|
2019
Q3 | $2K | Buy |
318
+6
| +2% | +$41 | ﹤0.01% | 6225 |
|
|
2019
Q2 | $2K | Sell |
312
-1
| -0.3% | -$8 | ﹤0.01% | 6199 |
|
|
2019
Q1 | $3K | Hold |
313
| – | – | ﹤0.01% | 5833 |
|
|
2018
Q4 | $2K | Hold |
313
| – | – | ﹤0.01% | 6224 |
|
|
2018
Q3 | $6K | Sell |
313
-154
| -33% | -$2.8K | ﹤0.01% | 6098 |
|
|
2018
Q2 | $9K | Sell |
467
-2,183
| -82% | -$32.2K | ﹤0.01% | 5988 |
|
|
2018
Q1 | $28K | Sell |
2,650
-949
| -26% | -$15.2K | ﹤0.01% | 5738 |
|
|
2017
Q4 | $152K | Sell |
3,599
-3,113
| -46% | -$140K | ﹤0.01% | 5108 |
|
|
2017
Q3 | $369K | Buy |
6,712
+3,863
| +136% | +$652K | ﹤0.01% | 4538 |
|
|
2017
Q2 | $528K | Buy |
2,849
+45
| +2% | +$7.89K | ﹤0.01% | 4189 |
|
|
2017
Q1 | $335K | Buy |
2,804
+716
| +34% | +$75K | ﹤0.01% | 4509 |
|
|
2016
Q4 | $207K | Buy |
2,088
+1,072
| +106% | +$113K | ﹤0.01% | 4752 |
|
|
2016
Q3 | $113K | Buy |
1,016
+14
| +1% | +$1.68K | ﹤0.01% | 4842 |
|
|
2016
Q2 | $103K | Sell |
1,002
-161
| -14% | -$16.1K | ﹤0.01% | 4814 |
|
|
2016
Q1 | $107K | Buy |
1,163
+146
| +14% | +$15.6K | ﹤0.01% | 4782 |
|
|
2015
Q4 | $147K | Buy |
1,017
+1,010
| +14,429% | +$131K | ﹤0.01% | 4656 |
|
|
2015
Q3 | $1K | Buy |
+7
| New | +$821 | ﹤0.01% | 6097 |
|
Other funds holding SIOX
JC
CIA
BBA
Wells Fargo's SIOX Position: Q1 2023 in Review
Wells Fargo sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 2,373 shares — an estimated $1.03K sold.
Wells Fargo first reported a position in SIOX in Q3 2015 and held it in 30 quarters. The position peaked at $528K in Q2 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.
- Wells Fargo reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Wells Fargo sold 2,373 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $1.03K.
- Wells Fargo first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 30 quarters.
- Wells Fargo's Sio Gene Therapies Inc. Common Stock position peaked at $528K in Q2 2017.
- 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.
Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.